Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Evaxion Biotech A/S ADR
(NQ:
EVAX
)
2.925
+0.015 (+0.52%)
Streaming Delayed Price
Updated: 3:04 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evaxion Biotech A/S ADR
< Previous
1
2
3
4
5
6
7
Next >
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
March 23, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for Cancer Research Annual Meeting (AACR)
March 14, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
March 06, 2023
On Monday, 36 companies set new 52-week lows.
Via
Benzinga
Evaxion Biotech Highlights Promising Data From Personalized Cancer Immunotherapy
November 17, 2022
Via
Benzinga
Evaxion Biotech, Pantherna Reveals Encouraging Data From mRNA-Based Cancer Vaccine
February 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 08, 2023
Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday!
Via
InvestorPlace
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
February 08, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion receives FDA fast-track designation for personalized cancer immunotherapy
January 19, 2023
From
Evaxion Biotech
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 03, 2023
Via
Benzinga
Evaxion receives approval from FDA to proceed with the clinical Phase 2b study for EVX-01
January 03, 2023
From
Evaxion Biotech
Via
GlobeNewswire
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket
December 30, 2022
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...
Via
Benzinga
Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023
December 15, 2022
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion, ExpreS2ion Ink Research Pact For Cytomegalovirus Vaccine Candidate
December 06, 2022
Via
Benzinga
Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate
December 06, 2022
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion announces promising results from Phase 1/2a clinical trial of personalized DNA cancer immunotherapy EVX-02
November 17, 2022
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Announces Third Quarter 2022 Financial Results and Business Update
November 14, 2022
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion CEO comments on strategic focus
November 10, 2022
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion welcomes Per Norlén as new CEO.
October 05, 2022
From
Evaxion Biotech
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
Via
Benzinga
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
September 28, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 27, 2022
Gainers
Via
Benzinga
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
September 27, 2022
Gainers
Via
Benzinga
US Stocks Open Higher; Dow Surges 300 Points
September 27, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 300 points on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 22, 2022
Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.
Via
Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
September 26, 2022
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 22, 2022
It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.
Via
InvestorPlace
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
September 22, 2022
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...
Via
Benzinga
US Stocks Edge Higher As Fed Raises Interest Rates By 75 Basis Points
September 21, 2022
U.S. stocks traded slightly higher toward the end of trading session on Wednesday following the announcement of interest rate decision by the Fed.
Via
Benzinga
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.